Abstract
OBJECTIVE--To describe the treatment of cancer pain in France and to evaluate the predictive factors for inadequate management. DESIGN--Multicentre, representative cross sectional survey. SETTING--20 treatment centres, including cancer centres, university hospitals, state hospitals, private clinics, and one homecare setting (in which patients are supported at home). SUBJECTS--605 patients with cancer. MAIN MEASURES--Patients rated prevalence and severity of pain and functional impairment related to pain. Doctors reported patients' cancer characteristic, performance status, pain severity, and analgesic drugs ordered. RESULTS--57% (340/601) of patients with cancer reported pain due to their disease, and, of those with pain, 69% (224/325) rated their worst pain at a level that impaired their ability to function. 30% (84/279) were reported as receiving no drugs for their pain. Of the 270 patients in pain for whom information on treatment was available 51% (137/270) were not receiving adequate pain relief, according to an index based on the World Health Organisation's guidelines. French doctors were found to underestimate the severity of their patients' pain. Younger patients, patients without metastatic disease, patients with a better performance status, and patients who rated their pain as more severe than their doctors did were at greater risk for undertreatment of their pain. CONCLUSIONS--In the light of the high prevalence and the severity of pain among patients with cancer, the assessment and treatment of cancer pain in France remain inadequate, emphasising the need for changes in patient care.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brasseur L., Larue F. France: status of cancer pain and palliative care. J Pain Symptom Manage. 1993 Aug;8(6):412–415. doi: 10.1016/0885-3924(93)90066-5. [DOI] [PubMed] [Google Scholar]
- Cleeland C. S., Gonin R., Hatfield A. K., Edmonson J. H., Blum R. H., Stewart J. A., Pandya K. J. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med. 1994 Mar 3;330(9):592–596. doi: 10.1056/NEJM199403033300902. [DOI] [PubMed] [Google Scholar]
- Cleeland C. Research in cancer pain. What we know and what we need to know. Cancer. 1991 Feb 1;67(3 Suppl):823–827. doi: 10.1002/1097-0142(19910201)67:3+<823::aid-cncr2820671412>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
- Daut R. L., Cleeland C. S. The prevalence and severity of pain in cancer. Cancer. 1982 Nov 1;50(9):1913–1918. doi: 10.1002/1097-0142(19821101)50:9<1913::aid-cncr2820500944>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
- Foley K. M. The treatment of cancer pain. N Engl J Med. 1985 Jul 11;313(2):84–95. doi: 10.1056/NEJM198507113130205. [DOI] [PubMed] [Google Scholar]
- Greenwald H. P., Bonica J. J., Bergner M. The prevalence of pain in four cancers. Cancer. 1987 Nov 15;60(10):2563–2569. doi: 10.1002/1097-0142(19871115)60:10<2563::aid-cncr2820601036>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
- Von Roenn J. H., Cleeland C. S., Gonin R., Hatfield A. K., Pandya K. J. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med. 1993 Jul 15;119(2):121–126. doi: 10.7326/0003-4819-119-2-199307150-00005. [DOI] [PubMed] [Google Scholar]